Page last updated: 2024-09-03

imatinib mesylate and Dermatitis Medicamentosa

imatinib mesylate has been researched along with Dermatitis Medicamentosa in 72 studies

Research

Studies (72)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	43 (59.72)	29.6817
2010's	26 (36.11)	24.3611
2020's	3 (4.17)	2.80

Authors

Authors	Studies
Alevizopoulos, N; Alexandris, D; Gakiopoulou, C; Kanellis, G; Marinos, L	1
Almheirat, Y; Bouabdalla, S; Daflaoui, H; Dikhaye, S; Zizi, N	1
Huang, W; Li, J; Li, X; Qiu, F; Wu, X; Yao, G; Zhang, J; Zhu, S	1
Chung, HJ; Keller, M; Penn, EH	1
Cho, H; Doki, Y; Hahn, S; Hirota, S; Honda, H; Im, SA; Ishikawa, T; Kang, YK; Kong, SH; Kurokawa, Y; Kwon, OK; Lee, HJ; Lee, KH; Masuzawa, T; Matsumoto, S; Nabeshima, K; Nishida, T; Park, SR; Ryu, MH; Shimokawa, T; Yang, HK; Yook, JH	1
Nambudiri, VE; Shi, CR	1
Dogra, S; Handa, S; Khadwal, A; Kumari, S; Lad, D; Malhotra, P; Prakash, G; Suri, V; Varma, S; Vinay, K; Yanamandra, U	1
Capusan, TM; de Argila, D; Herrero-Moyano, M; Martinez-Mera, C; Steegmann Olmedillas, JL; Urquía Renke, A	1
Chen, WS; Chen, YJ; Juan, CK; Yang, CS	1
Butt, G; Khokar, A; Malik, U; Naumeri, F	1
Esturo, SV; Moreno, AJ; Pérez, NO; Valls, AT; Viladomiu, Edel A	1
Carrascosa, R; Fraga, J; García Diez, A; Llamas-Velasco, M; Requena, L; Steegmann, JL	1
Ormaechea-Pérez, N; Pretel-Irazabal, M; Tuneu-Valls, A	1
Carrascosa, JM; Ferrandiz, C; Plana, A; Vilavella, M	1
Chu, A; Kubba, F; Lee, M; Scott, AD	1
Allegra, A; Alonci, A; Calapai, G; Gangemi, S; Maisano, V; Mannucci, C; Musolino, C; Russo, S	1
Akin Belli, A; Ayer, M; Barut, SG; Dervis, E	1
Chang, SE; Choi, JH; Kang, YK; Lee, JH; Lee, MW; Lee, WJ; Moon, KC; Won, CH	1
Provost, N; Vadeboncoeur, S	1
Ambrifi, M; Bottoni, U; Calvieri, S; Clerico, R; Corsetti, P; Didona, D; Paolino, G	1
Battistella, M; Dubertret, L; Frémont, G; Gornet, JM; Vignon-Pennamen, MD; Viguier, M	1
Basso, FG; Boer, CC; Cintra, ML; Corrêa, ME; da Silva Santos, P; de Magalhães, MH; de Souza, CA; Torrezan, M	1
Bousema, MT; Hayes, DP; Kardaun, SH; Kramer, MH; Timmer-de Mik, L	1
Cheng, H; Geist, DE; Piperdi, B; Piperdi, M; Virk, R	1
Blaya-Alvarez, B; Díaz-Pérez, JL; González-Hermosa, MA; Martínez de Lagrán, Z	1
Casado, M; Feito, M; Feltes, R; Floristán, U; Herranz, P; Mariño-Enriquez, A; Ramírez, P; Sendagorta, E	1
Bienz, N; Dickens, E; Lewis, F	1
Murphy, G; Verma, SM	1
Hasegawa, M; Ishikawa, O; Kuraishi, N; Nagai, Y	1
Schiffer, CA; Zonder, JA	1
Etienne, G; Milpied, B; Nicolini, FE; Réa, D; Rigal-Huguet, F; Tulliez, M	1
Alimena, G; Breccia, M	1
Kishimoto, H; Nakamura, M; Otagiri, N; Sasahara, K; Tauchi, K; Tsukada, Y; Yoshifuku, S	1
Bouvresse, S; Clérici, T; de Masson, A; Mahé, E; Saïag, P	1
Craddock, C; Novitzky-Basso, I	1
Horne, HL; Maung, Z; Reddy, H	1
Benchekroun, S; Benchikhi, H; Hali, F; Lamchahab, M; Qachouh, M; Quessar, A	1
Lim, DS; Muir, J	1
Dimopoulou, M; Konstantopoulos, K; Kourelis, C; Meletis, J; Papadogianni, A	1
Crossman, LC; O'Brien, SG; Rule, SA	1
Bachot, N; Bastuji-Garin, S; Berthaud, P; Giraudier, S; Revuz, J; Tulliez, M; Valeyrie, L; Wechsler, J	1
Douglas, WS; Drummond, A; Drummond, MW; Hay, I; Holyoake, TL; Micallef-Eynaud, P	1
Calvo, F; Giraudier, S; Larghero, J; Raffoux, E; Rousselot, P; Rybojad, M; Tulliez, M	1
Audring, H; Baskaynak, G; Dörken, B; Kreuzer, KA; le Coutre, P; Riess, H; Schwarz, M; Zuber, J	1
Deininger, MW; Druker, BJ; Ford, JM; O'Brien, SG	1
Duncan, E; Mufti, G; Raj, K	1
Guilhot, F	1
Barbaud, A; Schmutz, JL; Trechot, P	1
Ardau, R; Chillotti, C; De Lisa, R; Del Zompo, M; Severino, G	1
Sawamura, D; Shimizu, H; Yanagi, T	1
Alimena, G; Breccia, M; Carmosino, I; Latagliata, R; Morano, SG; Russo, E	1
Shimizu, H; Shimizu, T; Ujiie, H	1
Chiarolini, F; Cossu, A; Ena, P; Siddi, GM	1
Cho, BK; Cho, DH; Kim, HJ; Kim, HS; Lee, AW; Lee, JY; Park, HJ; Yoon, DY	1
Decosterd, LA; Duchosal, MA; Gambillara, E; Kovacsovics, T; Laffitte, E; Panizzon, RG; Widmer, N	1
Iwazawa, T; Katsushima, S; Matsui, S; Monden, T; Nakano, Y; Ohnishi, T; Okamoto, S; Takemoto, H; Tono, T; Yano, H	1
Scheinfeld, N	1
Alomar, A; Dalmau, J; Fernández-Figueras, MT; Peramiquel, L; Puig, L; Roé, E	1
Deguchi, N; Kawamura, T; Kitamura, R; Matsue, H; Shibagaki, N; Shimada, S; Shimizu, A; Yanagi, M	1
De Raeve, H; Lambert, J; Van de Voorde, K; Van Regenmortel, N	1
Asahina, A; Fujimoto, M; Ihn, H; Kuwano, Y; Tamaki, K; Watanabe, R	1
Alonso, V; García, L; Jordá, E; Martín, JM; Monteagudo, C; Villalón, G	1
Almagro, M; del Pozo, J; Fonseca, E; Martínez-González, MC; Pérez, M; Yebra-Pimentel, MT	1
Neoh, CY; Ng, SK; Tan, AW	1
Cholongitas, E; Dasenaki, M; Katsogridakis, K; Pipili, C; Relos, K	1
Chang, HJ; Cho, MS; Choi, MY; Kong, JH; Kwon, JM; Lee, KE; Lee, SM; Lee, SN; Mun, YC; Nam, E; Nam, SH; Seong, CM; Yoo, SH	1
Chevreau, C; Delord, JP; Deslandres, M; Sibaud, V	1
Burgin, S; Heidary, N; Naik, H	1
Brouard, M; Saurat, JH	1
Brouard, MC; Mach-Pascual, S; Prins, C; Saurat, JH	1
Chen, PM; Chiou, TJ; Chung, HM; Fan, FS; Hsiao, LT; Lin, JT; Liu, JH; Wang, WS; Yen, CC	1

Reviews

11 review(s) available for imatinib mesylate and Dermatitis Medicamentosa

Article	Year
Imatinib mesylate-induced lichenoid drug eruption. Cutis, 2017, Volume: 99, Issue:3 Topics: Aged, 80 and over; Drug Eruptions; Humans; Imatinib Mesylate; Lichenoid Eruptions; Male; Protein Kinase Inhibitors	2017
Adverse skin effects of imatinib, a tyrosine kinase inhibitor. Actas dermo-sifiliograficas, 2014, Volume: 105, Issue:7 Topics: Drug Eruptions; Humans; Imatinib Mesylate; Protein-Tyrosine Kinases	2014
Lichenoid drug eruption related to imatinib: report of a new case and review of the literature. Clinical and experimental dermatology, 2009, Volume: 34, Issue:7 Topics: Aged; Antineoplastic Agents; Benzamides; Drug Eruptions; Humans; Imatinib Mesylate; Lichenoid Eruptions; Male; Mouth Diseases; Piperazines; Pyrimidines	2009
Lichenoid drug eruption with palmoplantar hyperkeratosis due to imatinib mesylate: a case report and a review of the literature. Acta dermato-venereologica, 2010, Volume: 90, Issue:1 Topics: Administration, Topical; Adrenal Cortex Hormones; Aged; Aged, 80 and over; Antineoplastic Agents; Benzamides; Dermatologic Agents; Dose-Response Relationship, Drug; Drug Eruptions; Female; Humans; Imatinib Mesylate; Keratoderma, Palmoplantar; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lichenoid Eruptions; Male; Middle Aged; Piperazines; Pyrimidines; Recurrence; Skin; Treatment Outcome	2010
Update on practical aspects of the treatment of chronic myeloid leukemia with imatinib mesylate. Current hematologic malignancy reports, 2006, Volume: 1, Issue:3 Topics: Algorithms; Antineoplastic Agents; Benzamides; Blast Crisis; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Combined Modality Therapy; Dasatinib; Drug Eruptions; Drug Interactions; Edema; Fusion Proteins, bcr-abl; Gastrointestinal Diseases; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Salvage Therapy; Thiazoles	2006
Pleural/pericardic effusions during dasatinib treatment: incidence, management and risk factors associated to their development. Expert opinion on drug safety, 2010, Volume: 9, Issue:5 Topics: Aged; Antineoplastic Agents; Autoimmune Diseases; Benzamides; Cardiovascular Diseases; Clinical Trials as Topic; Comorbidity; Dasatinib; Disease Management; Drug Administration Schedule; Drug Eruptions; Humans; Hypercholesterolemia; Imatinib Mesylate; Incidence; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukocyte Count; Pericardial Effusion; Piperazines; Pleural Effusion; Protein Kinase Inhibitors; Pyrimidines; Risk Factors; Thiazoles; Treatment Outcome	2010
Practical management of patients with chronic myeloid leukemia receiving imatinib. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003, Apr-15, Volume: 21, Issue:8 Topics: Antineoplastic Agents; Arthralgia; Benzamides; Bone Marrow; Diarrhea; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Eruptions; Drug Interactions; Edema; Enzyme Inhibitors; Fusion Proteins, bcr-abl; Hematopoietic Cell Growth Factors; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Liver; Muscle Cramp; Nausea; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Vomiting	2003
Indications for imatinib mesylate therapy and clinical management. The oncologist, 2004, Volume: 9, Issue:3 Topics: Antineoplastic Agents; Benzamides; Bone Marrow; Chemical and Drug Induced Liver Injury; Drug Eruptions; Edema; Enzyme Inhibitors; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Muscle Cramp; Piperazines; Pyrimidines	2004
Imatinib mesylate and dermatology part 2: a review of the cutaneous side effects of imatinib mesylate. Journal of drugs in dermatology : JDD, 2006, Volume: 5, Issue:3 Topics: Antineoplastic Agents; Benzamides; Drug Eruptions; Humans; Imatinib Mesylate; Piperazines; Protein-Tyrosine Kinases; Pyrimidines	2006
[Cutaneous side effects associated with epidermal growth factor receptor and tyrosine kinase inhibitors]. Annales de dermatologie et de venereologie, 2008, Volume: Spec No 1 Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Benzamides; Benzenesulfonates; Cetuximab; Drug Eruptions; ErbB Receptors; Erlotinib Hydrochloride; Humans; Imatinib Mesylate; Indoles; Niacinamide; Phenylurea Compounds; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyridines; Pyrimidines; Pyrroles; Quinazolines; Sorafenib; Sunitinib	2008
Chemotherapeutic agents and the skin: An update. Journal of the American Academy of Dermatology, 2008, Volume: 58, Issue:4 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antimetabolites; Antineoplastic Agents; Benzamides; Benzenesulfonates; Cetuximab; Drug Eruptions; Drug-Related Side Effects and Adverse Reactions; ErbB Receptors; Erlotinib Hydrochloride; Fusion Proteins, bcr-abl; Gefitinib; Hair Diseases; Humans; Imatinib Mesylate; Indoles; Mucous Membrane; Nail Diseases; Niacinamide; Phenylurea Compounds; Piperazines; Platinum Compounds; Proteasome Inhibitors; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyridines; Pyrimidines; Pyrroles; Quinazolines; Signal Transduction; Skin; Skin Diseases; Sorafenib; Sunitinib; Taxoids	2008

Trials

1 trial(s) available for imatinib mesylate and Dermatitis Medicamentosa

Article	Year
Phase II study of neoadjuvant imatinib in large gastrointestinal stromal tumours of the stomach. British journal of cancer, 2017, Jun-27, Volume: 117, Issue:1 Topics: Adult; Aged; Antineoplastic Agents; Disease-Free Survival; Drug Eruptions; Female; Gastrectomy; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Japan; Male; Middle Aged; Neoadjuvant Therapy; Neutropenia; Organ Sparing Treatments; Republic of Korea; Stomach Neoplasms; Tumor Burden	2017

Article

Year

Phase II study of neoadjuvant imatinib in large gastrointestinal stromal tumours of the stomach.

British journal of cancer, 2017, Jun-27, Volume: 117, Issue:1

Topics: Adult; Aged; Antineoplastic Agents; Disease-Free Survival; Drug Eruptions; Female; Gastrectomy; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Japan; Male; Middle Aged; Neoadjuvant Therapy; Neutropenia; Organ Sparing Treatments; Republic of Korea; Stomach Neoplasms; Tumor Burden

2017

Other Studies

60 other study(ies) available for imatinib mesylate and Dermatitis Medicamentosa

Article	Year
Lichenoid drug eruption associated with imatinib mesylate therapy. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2023, Volume: 29, Issue:1 Topics: Drug Eruptions; Humans; Imatinib Mesylate; Lichen Planus; Lichenoid Eruptions; Protein Kinase Inhibitors	2023
Imatinib-induced lichen planus and lichenoid drug eruption: A report of three cases. Journal of cutaneous pathology, 2023, Volume: 50, Issue:5 Topics: Drug Eruptions; Hepatitis B; Humans; Imatinib Mesylate; Lichen Planus; Lichenoid Eruptions	2023
Therapeutic drug monitoring-based dose optimization for imatinib-associated serious cutaneous reactions in a patient with gastrointestinal stromal tumours: A case report. Journal of clinical pharmacy and therapeutics, 2020, Volume: 45, Issue:4 Topics: Aged; Drug Eruptions; Drug Monitoring; Eczema; Female; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Skin Diseases	2020
Imatinib-induced psoriasiform eruption in a patient with chronic myeloid leukemia. American journal of hematology, 2018, Volume: 93, Issue:3 Topics: Adult; Antineoplastic Agents; Drug Eruptions; Female; Hand Dermatoses; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Molecular Targeted Therapy; Protein Kinase Inhibitors; Scalp Dermatoses; Skin Diseases, Papulosquamous	2018
Long-term mucocutaneous adverse effects of imatinib in Indian chronic myeloid leukemia patients. International journal of dermatology, 2018, Volume: 57, Issue:3 Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Agents; Cross-Sectional Studies; Drug Eruptions; Edema; Eye Diseases; Female; Humans; Hyperpigmentation; Hypopigmentation; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lichenoid Eruptions; Male; Middle Aged; Mouth Diseases; Mouth Mucosa; Nail Diseases; Sex Factors; Skin Diseases, Vesiculobullous; Time Factors; Young Adult	2018
Imatinib-induced pseudoporphyria. Clinical and experimental dermatology, 2018, Volume: 43, Issue:4 Topics: Antineoplastic Agents; Drug Eruptions; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Middle Aged; Porphyrias; Skin	2018
Pemphigus foliaceus associated with imatinib therapy in a patient with gastrointestinal stromal tumor. International journal of dermatology, 2018, Volume: 57, Issue:10 Topics: Antineoplastic Agents; Chemotherapy, Adjuvant; Drug Eruptions; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Male; Middle Aged; Pemphigus	2018
Cutaneous manifestations in chronic myeloid leukemia in chronic phase treated with imatinib. International journal of dermatology, 2019, Volume: 58, Issue:9 Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Child; Cross-Sectional Studies; Dose-Response Relationship, Drug; Drug Eruptions; Female; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Leukemia, Myeloid, Chronic-Phase; Male; Middle Aged; Pakistan; Philadelphia Chromosome; Protein Kinase Inhibitors; Time Factors; Young Adult	2019
Pseudoporphyria induced by imatinib mesylate. International journal of dermatology, 2014, Volume: 53, Issue:2 Topics: Antineoplastic Agents; Benzamides; Drug Eruptions; Hand Dermatoses; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Piperazines; Porphyrins; Pyrimidines; Skin Diseases, Vesiculobullous	2014
Perforating folliculitis in a patient treated with nilotinib: a further evidence of C-kit involvement. The American Journal of dermatopathology, 2014, Volume: 36, Issue:7 Topics: Antineoplastic Combined Chemotherapy Protocols; Benzamides; Dasatinib; Drug Eruptions; Folliculitis; Hair Follicle; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Piperazines; Pyrimidines; Thiazoles	2014
Pityriasis rubra pilaris-like reaction induced by imatinib. Clinical and experimental dermatology, 2013, Volume: 38, Issue:5 Topics: Antineoplastic Agents; Benzamides; Drug Eruptions; Humans; Imatinib Mesylate; Male; Middle Aged; Piperazines; Pityriasis Rubra Pilaris; Protein Kinase Inhibitors; Pyrimidines	2013
Acute generalized exanthematous pustulosis (AGEP) secondary to imatinib in a patient with chronic myeloid leukaemia. Clinical and experimental dermatology, 2015, Volume: 40, Issue:8 Topics: Acute Generalized Exanthematous Pustulosis; Aged; Antineoplastic Agents; Drug Eruptions; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive	2015
Possible Role of Interleukin-31/33 Axis in Imatinib Mesylate-Associated Skin Toxicity. Turkish journal of haematology : official journal of Turkish Society of Haematology, 2015, Volume: 32, Issue:2 Topics: Aged; Antineoplastic Agents; Drug Eruptions; Humans; Imatinib Mesylate; Interleukin-1 Receptor-Like 1 Protein; Interleukin-33; Interleukins; Keratinocytes; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Mast Cells; Protein Kinase Inhibitors; Pruritus	2015
Cutaneous adverse reactions of imatinib therapy in patients with chronic myeloid leukemia: A six-year follow up. European journal of dermatology : EJD, 2016, Apr-01, Volume: 26, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Alopecia; Antineoplastic Agents; Cheilitis; Cross-Sectional Studies; Drug Eruptions; Edema; Exanthema; Female; Follow-Up Studies; Humans; Hyperhidrosis; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Pigmentation Disorders; Stomatitis, Aphthous; Time Factors; Young Adult	2016
Clinical and histopathologic analysis of 46 cases of cutaneous adverse reactions to imatinib. International journal of dermatology, 2016, Volume: 55, Issue:5 Topics: Antineoplastic Agents; Dose-Response Relationship, Drug; Drug Eruptions; Edema; Erythema Multiforme; Female; Humans; Imatinib Mesylate; Lichenoid Eruptions; Male; Middle Aged; Parakeratosis; Retrospective Studies; Severity of Illness Index; Time Factors	2016
Multiple Xanthogranulomas in an Adult: Known Entity, New Association. Journal of cutaneous medicine and surgery, 2016, Volume: 20, Issue:5 Topics: Adult; Antineoplastic Agents; Chemotherapy, Adjuvant; Drug Eruptions; Female; Gastrointestinal Stromal Tumors; Granuloma; Histiocytosis, Non-Langerhans-Cell; Humans; Imatinib Mesylate; Stomach Neoplasms; Xanthomatosis	2016
Skin lesions in patients treated with imatinib mesylate: a 5-year prospective study. Cutis, 2016, Volume: 97, Issue:6 Topics: Antineoplastic Agents; Carcinoma, Basal Cell; Dermatitis, Seborrheic; Dermatomycoses; Drug Eruptions; Eczema; Edema; Female; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Histiocytoma, Benign Fibrous; Humans; Imatinib Mesylate; Keratosis, Actinic; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Nail Diseases; Orbital Diseases; Prospective Studies; Pruritus; Psoriasis; Skin Neoplasms	2016
Imatinib-induced hand-foot syndrome in a patient with metastatic gastrointestinal stromal tumor. Archives of dermatology, 2008, Volume: 144, Issue:10 Topics: Benzamides; Biopsy, Needle; Drug Eruptions; Erythema; Follow-Up Studies; Foot Dermatoses; Gastrointestinal Stromal Tumors; Hand Dermatoses; Humans; Imatinib Mesylate; Immunohistochemistry; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Piperazines; Protein Kinase Inhibitors; Pyloric Antrum; Pyrimidines; Risk Assessment; Stomach Neoplasms; Syndrome	2008
Skin and oral lesions associated to imatinib mesylate therapy. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2009, Volume: 17, Issue:4 Topics: Aged, 80 and over; Antineoplastic Agents; Benzamides; Dose-Response Relationship, Drug; Drug Eruptions; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Oral Ulcer; Piperazines; Protein Kinase Inhibitors; Pyrimidines	2009
Imatinib-induced pseudoporphyria. Clinical and experimental dermatology, 2009, Volume: 34, Issue:6 Topics: Adult; Antineoplastic Agents; Benzamides; Cytarabine; Drug Eruptions; Drug Therapy, Combination; Humans; Imatinib Mesylate; Leukemia, Myeloid; Male; Piperazines; Porphyrias; Pyrimidines	2009
Management of imatinib-related exacerbation of psoriasis in a patient with a gastrointestinal stromal tumour. The Australasian journal of dermatology, 2009, Volume: 50, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Benzamides; Drug Eruptions; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Methotrexate; Middle Aged; Peritoneal Neoplasms; Piperazines; Psoriasis; Pyrimidines; Treatment Outcome	2009
[A case of lichen planus associated to treatment with imatinib]. Medicina clinica, 2009, Nov-28, Volume: 133, Issue:20 Topics: Antineoplastic Agents; Benzamides; Drug Eruptions; Humans; Imatinib Mesylate; Lichen Planus; Male; Middle Aged; Piperazines; Pyrimidines	2009
Imatinib: a designer drug, another cutaneous complication. Clinical and experimental dermatology, 2009, Volume: 34, Issue:5 Topics: Antineoplastic Agents; Benzamides; Drug Eruptions; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Nail Diseases; Piperazines; Protein Kinase Inhibitors; Psoriasis; Pyrimidines	2009
Skin fragility and blistering with imatinib mesylate. Journal of the European Academy of Dermatology and Venereology : JEADV, 2010, Volume: 24, Issue:4 Topics: Antineoplastic Agents; Benzamides; Blister; Drug Eruptions; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Middle Aged; Piperazines; Pyrimidines; Skin	2010
[Guidelines for the management of nilotinib (Tasigna)-induced side effects in chronic myelogenous leukemia: recommendations of French Intergroup of CML (Fi-LMC group)]. Bulletin du cancer, 2010, Volume: 97, Issue:8 Topics: Antineoplastic Agents; Benzamides; Drug Eruptions; Drug Interactions; Drug Resistance, Neoplasm; Erythropoietin; Fertility; Food-Drug Interactions; France; Granulocyte Colony-Stimulating Factor; Heart Diseases; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Metabolic Diseases; Neutropenia; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Recombinant Proteins	2010
[Complete response achieved in a case of gastric gastrointestinal stromal tumor by administration of imatinib mesilate with concurrent relatively high-dose steroid therapy to control side effects]. Gan to kagaku ryoho. Cancer & chemotherapy, 2010, Volume: 37, Issue:11 Topics: Benzamides; Drug Eruptions; Drug Therapy, Combination; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Male; Middle Aged; Neoplasm Metastasis; Piperazines; Prednisolone; Pruritus; Pyrimidines; Treatment Outcome	2010
[Recurrent neutrophilic panniculitis in a patient with chronic myelogenous leukaemia treated with imatinib mesilate and dasatinib]. Annales de dermatologie et de venereologie, 2011, Volume: 138, Issue:2 Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Biopsy; Dasatinib; Drug Eruptions; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Neutrophils; Panniculitis; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Recurrence; Skin; Thiazoles	2011
Cross-intolerance to imatinib, dasatinib and nilotinib therapy in a patient with chronic myeloid leukaemia. European journal of haematology, 2011, Volume: 86, Issue:6 Topics: Antineoplastic Agents; Benzamides; Cross Reactions; Dasatinib; Drug Eruptions; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Middle Aged; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Thiazoles	2011
Skin fragility and blistering secondary to imatinib. Clinical and experimental dermatology, 2012, Volume: 37, Issue:5 Topics: Antineoplastic Agents; Benzamides; Blister; Drug Eruptions; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Middle Aged; Piperazines; Pyrimidines; Skin Diseases	2012
[Successive cutaneous adverse reactions to nilotinib and imatinib in a single patient]. Annales de dermatologie et de venereologie, 2012, Volume: 139, Issue:12 Topics: Antineoplastic Agents; Benzamides; Drug Eruptions; Female; Humans; Imatinib Mesylate; Middle Aged; Piperazines; Pyrimidines	2012
Oral lichenoid reaction to imatinib (STI 571, Gleevec). Dermatology (Basel, Switzerland), 2002, Volume: 205, Issue:2 Topics: Aged; Antineoplastic Agents; Benzamides; Drug Eruptions; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lichenoid Eruptions; Mouth Diseases; Piperazines; Pyrimidines	2002
Pityriasis rosea associated with imatinib (STI571, Gleevec). Dermatology (Basel, Switzerland), 2002, Volume: 205, Issue:2 Topics: Adult; Antineoplastic Agents; Benzamides; Drug Eruptions; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Piperazines; Pityriasis Rosea; Pyrimidines	2002
Managing cutaneous reactions to imatinib therapy. Blood, 2002, Nov-01, Volume: 100, Issue:9 Topics: Adult; Aged; Benzamides; Drug Eruptions; Exanthema; Female; Humans; Imatinib Mesylate; Immunosuppressive Agents; Immunotherapy; Leukemia, Myeloid, Chronic-Phase; Piperazines; Prednisolone; Pyrimidines; Stevens-Johnson Syndrome	2002
Adverse cutaneous reactions to imatinib (STI571) in Philadelphia chromosome-positive leukemias: a prospective study of 54 patients. Journal of the American Academy of Dermatology, 2003, Volume: 48, Issue:2 Topics: Adult; Antineoplastic Agents; Benzamides; Dose-Response Relationship, Drug; Drug Eruptions; Edema; Exanthema; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Multivariate Analysis; Piperazines; Prospective Studies; Pruritus; Pyrimidines	2003
A spectrum of skin reactions caused by the tyrosine kinase inhibitor imatinib mesylate (STI 571, Glivec). British journal of haematology, 2003, Volume: 120, Issue:5 Topics: Antineoplastic Agents; Benzamides; Cohort Studies; Drug Eruptions; Enzyme Inhibitors; Follow-Up Studies; Humans; Imatinib Mesylate; Leukemia, Myeloid, Chronic-Phase; Piperazines; Prospective Studies; Pyrimidines	2003
Photosensitization in chronic myelogenous leukaemia patients treated with imatinib mesylate. British journal of haematology, 2003, Volume: 120, Issue:6 Topics: Adult; Antineoplastic Agents; Benzamides; Drug Eruptions; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Middle Aged; Photosensitivity Disorders; Piperazines; Pyrimidines	2003
Squamous cutaneous epithelial cell carcinoma in two CML patients with progressive disease under imatinib treatment. European journal of haematology, 2003, Volume: 70, Issue:4 Topics: Age Factors; Aged; Antineoplastic Agents; Benzamides; Carcinoma, Squamous Cell; Cocarcinogenesis; Coronary Disease; Drug Eruptions; Dyspnea; Enzyme Inhibitors; Facial Neoplasms; Humans; Hydroxyurea; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Pancytopenia; Piperazines; Pleural Effusion; Pyrimidines; Sunlight; Ultraviolet Rays	2003
Cutaneous drug reaction case reports: from the world literature. American journal of clinical dermatology, 2003, Volume: 4, Issue:5 Topics: Adult; Adverse Drug Reaction Reporting Systems; Aged; Benzamides; Clozapine; Cyclosporine; Diclofenac; Drug Eruptions; Female; Humans; Imatinib Mesylate; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Nimodipine; Paroxetine; Piperazines; Polyethylene Glycols; Prednisolone; Pyrimidines; Recombinant Proteins; Salicylamides; Spironolactone; Thioridazine; Vinblastine; Vinorelbine	2003
Erythema following imatinib mesylate. British journal of haematology, 2003, Volume: 122, Issue:1 Topics: Aged; Antineoplastic Agents; Benzamides; Drug Eruptions; Enzyme Inhibitors; Erythema; Humans; Imatinib Mesylate; Male; Piperazines; Protein-Tyrosine Kinases; Pyrimidines	2003
[Cutaneous side effects with imatinib (Glivec)]. Annales de dermatologie et de venereologie, 2004, Volume: 131, Issue:5 Topics: Benzamides; Drug Eruptions; Enzyme Inhibitors; Humans; Imatinib Mesylate; Piperazines; Pyrimidines	2004
Adverse reactions during imatinib and lansoprazole treatment in gastrointestinal stromal tumors. The Annals of pharmacotherapy, 2005, Volume: 39, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Antineoplastic Agents; Benzamides; Drug Eruptions; Edema; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Lansoprazole; Middle Aged; Omeprazole; Piperazines; Proton Pump Inhibitors; Pyrimidines; Stevens-Johnson Syndrome	2005
Follicular mucinosis associated with imatinib (STI571). The British journal of dermatology, 2004, Volume: 151, Issue:6 Topics: Antineoplastic Agents; Benzamides; Drug Eruptions; Facial Dermatoses; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Middle Aged; Mucinosis, Follicular; Piperazines; Pyrimidines	2004
Early and tardive skin adverse events in chronic myeloid leukaemia patients treated with imatinib. European journal of haematology, 2005, Volume: 74, Issue:2 Topics: Adult; Aged; Antineoplastic Agents; Benzamides; Carcinoma; Drug Eruptions; Edema; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Nausea; Piperazines; Pyrimidines; Skin Neoplasms; Vomiting; Weight Gain	2005
Cutaneous reactions to imatinib mesylate treated by topical steroid. American journal of hematology, 2005, Volume: 78, Issue:3 Topics: Administration, Cutaneous; Adult; Antineoplastic Agents; Benzamides; Betamethasone; Drug Eruptions; Fluprednisolone; Humans; Imatinib Mesylate; Male; Methylprednisolone; Middle Aged; Ointments; Piperazines; Pyrimidines; Steroids	2005
Oral lichenoid eruption secondary to imatinib (Glivec). The Journal of dermatological treatment, 2004, Volume: 15, Issue:4 Topics: Antineoplastic Agents; Benzamides; Drug Eruptions; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Lichenoid Eruptions; Male; Middle Aged; Mouth Diseases; Piperazines; Protein-Tyrosine Kinases; Pyrimidines	2004
Immunohistochemical characterization of cutaneous drug eruptions by STI571. Journal of dermatological science, 2005, Volume: 38, Issue:1 Topics: Adult; Anti-Bacterial Agents; Benzamides; Case-Control Studies; Child; Drug Eruptions; Female; Humans; Imatinib Mesylate; Immunohistochemistry; Immunophenotyping; Interleukin-1; Interleukin-18; Male; Middle Aged; Piperazines; Pyrimidines; Skin	2005
Severe pustular eruption associated with imatinib and voriconazole in a patient with chronic myeloid leukemia. Dermatology (Basel, Switzerland), 2005, Volume: 211, Issue:4 Topics: Adult; Antifungal Agents; Antineoplastic Agents; Aspergillosis; Benzamides; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Drug Eruptions; Drug Interactions; Enzyme Inhibitors; Exanthema; Humans; Imatinib Mesylate; Irritants; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lung Diseases, Fungal; Male; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Triazoles; Voriconazole	2005
[Gastrointestinal stromal tumor successfully treated with re-administration of STI571 despite of serious skin rash: a case report]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2005, Volume: 102, Issue:12 Topics: Aged; Antineoplastic Agents; Benzamides; Chemotherapy, Adjuvant; Drug Eruptions; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Mesentery; Neoplasm Recurrence, Local; Peritoneal Neoplasms; Piperazines; Pyrimidines	2005
Imatinib-associated lichenoid eruption: acitretin treatment allows maintained antineoplastic effect. The British journal of dermatology, 2006, Volume: 154, Issue:6 Topics: Acitretin; Aged; Antineoplastic Agents; Benzamides; Drug Eruptions; Humans; Imatinib Mesylate; Keratolytic Agents; Lichenoid Eruptions; Male; Middle Aged; Piperazines; Pyrimidines	2006
Imatinib mesylate causes palmoplantar hyperkeratosis and nail dystrophy in three patients with chronic myeloid leukaemia. The British journal of dermatology, 2006, Volume: 154, Issue:6 Topics: Aged; Antineoplastic Agents; Benzamides; Drug Eruptions; Female; Humans; Imatinib Mesylate; Keratoderma, Palmoplantar; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Nail Diseases; Piperazines; Pyrimidines	2006
Imatinib-induced eccrine squamous syringometaplasia. Journal of the American Academy of Dermatology, 2006, Volume: 55, Issue:2 Suppl Topics: Antineoplastic Agents; Benzamides; Drug Eruptions; Eccrine Glands; Female; Humans; Imatinib Mesylate; Metaplasia; Middle Aged; Piperazines; Pyrimidines; Sweat Gland Diseases	2006
Heliotrope-like eruption mimicking dermatomyositis in a patient treated with imatinib mesylate for chronic myeloid leukemia. International journal of dermatology, 2006, Volume: 45, Issue:10 Topics: Aged; Antineoplastic Agents; Benzamides; Dermatomyositis; Diagnosis, Differential; Drug Eruptions; Exanthema; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Piperazines; Pyrimidines	2006
Follicular acneiform eruption induced by imatinib. Journal of the European Academy of Dermatology and Venereology : JEADV, 2006, Volume: 20, Issue:10 Topics: Acne Vulgaris; Adult; Antineoplastic Agents; Benzamides; Drug Eruptions; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Piperazines; Pyrimidines	2006
Livedoid skin reaction probably due to imatinib therapy. The Annals of pharmacotherapy, 2007, Volume: 41, Issue:1 Topics: Adult; Aged; Benzamides; Drug Eruptions; Exanthema; Humans; Imatinib Mesylate; Male; Piperazines; Pyrimidines	2007
Sweet's syndrome: a spectrum of unusual clinical presentations and associations. The British journal of dermatology, 2007, Volume: 156, Issue:3 Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Benzamides; Drug Eruptions; Female; Hand Dermatoses; Hematologic Neoplasms; Humans; Imatinib Mesylate; Male; Middle Aged; Neutrophils; Piperazines; Pyrimidines; Retrospective Studies; Skin Diseases, Vesiculobullous; Sweet Syndrome	2007
Dermatitis after suspected imatinib-levothyroxine interaction in a patient with gastrointestinal stromal tumor. Cancer chemotherapy and pharmacology, 2008, Volume: 61, Issue:6 Topics: Aged; Antineoplastic Agents; Benzamides; Drug Eruptions; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Male; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Skin; Thyroxine	2008
Early imatinib-mesylate-induced hepatotoxicity in chronic myelogenous leukaemia. Acta haematologica, 2007, Volume: 118, Issue:4 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bile Ducts; Blast Crisis; Chemical and Drug Induced Liver Injury; Cholestasis, Intrahepatic; Cytarabine; Drug Eruptions; Hepatocytes; Humans; Idarubicin; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Liver Function Tests; Male; Middle Aged; Piperazines; Protein Kinase Inhibitors; Pyrimidines	2007
Cutaneous reactions to STI571. The New England journal of medicine, 2001, Aug-23, Volume: 345, Issue:8 Topics: Antineoplastic Agents; Benzamides; Dose-Response Relationship, Drug; Drug Eruptions; Exanthema; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Piperazines; Protein-Tyrosine Kinases; Pyrimidines	2001
Acute generalized exanthematous pustulosis associated with STI571 in a patient with chronic myeloid leukemia. Dermatology (Basel, Switzerland), 2001, Volume: 203, Issue:1 Topics: Acute Disease; Adult; Antineoplastic Agents; Benzamides; Diagnosis, Differential; Drug Eruptions; Enzyme Inhibitors; Exanthema; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Piperazines; Protein-Tyrosine Kinases; Pyrimidines	2001
Stevens-Johnson syndrome after treatment with STI571: a case report. British journal of haematology, 2002, Volume: 117, Issue:3 Topics: Adult; Antineoplastic Agents; Benzamides; Drug Eruptions; Enzyme Inhibitors; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Stevens-Johnson Syndrome	2002